Stereotaxis Reports 2021 Third Quarter Financial Results
11 nov. 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis Technology, Clinical Value and Innovations to be Highlighted at Society for Cardiac Robotic Navigation Meeting
08 nov. 2021 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announces it will attend...
Stereotaxis to Report Third Quarter 2021 Financial Results on November 11, 2021
28 oct. 2021 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
First Patients Treated in Southern Europe with Stereotaxis Genesis Robotic Technology
18 oct. 2021 07h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced installation of...
International Journal of Cardiology Publishes Data Demonstrating Superior Outcomes of Stereotaxis Robotic Cardiac Ablation in Pediatric Patients
12 oct. 2021 07h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in...
Stereotaxis to Present at Upcoming Investor Conferences
09 sept. 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Stereotaxis and MicroPort EP Collaborate to Advance Innovation and Adoption of Robotic Electrophysiology in China
30 août 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, China, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai Microport EP Medtech Co., Ltd. (“MicroPort EP”) today announced a broad collaboration to...
Stereotaxis Reports 2021 Second Quarter Financial Results
10 août 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.
26 juil. 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 26, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the appointment...
Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021
20 juil. 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 20, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...